Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence

British Journal of Pharmacology

Volumn 129, Issue 7, 2000, Pages 1423-1430

  Muscará, Marcelo N ^a   Vergnolle, Nathalie ^a   Lovren, Fina ^a   Triggle, Christopher R ^a   Elliott, Susan N ^a   Asfaha, Samuel ^a   Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cyclo oxygenase 2; Endothelium; Hypertension; Neutrophil adherence; Prostacyclin; Renal function

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARGIPRESSIN; CELECOXIB; CREATININE; CYCLOOXYGENASE 2; N(G) NITROARGININE METHYL ESTER; PROSTACYCLIN; RENIN; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME INHIBITION; HORMONE BLOOD LEVEL; HYPERTENSION; LEUKOCYTE ADHERENCE; MALE; MESENTERIC ARTERY; MESENTERIC VEIN; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS; RAT; THROMBOCYTE AGGREGATION; UREA BLOOD LEVEL; WEIGHT GAIN;

EID: 0034071374     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703232     Document Type: Article

References (32)

1. Asako, H., Kubes, P., Wallace, J.L., Wolf, R.E. & Granger, D.N. (1992). Modulation of leukocyte adherence in rat mesenteric venules by aspirin and salicylate. Gastroenterology, 103, 146-152.
2. Bishop-Bailey, D., Burke-Gaffney, A., Hellewell, P.G., Pepper, J.R. & Mitchell, J.A. (1998). Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 249, 44-47.
3. Boyce, S., Chan, C.C., Gordon, R., Li, C.-S., Rodger, I.W., Webb, J.K., Rupniak, N.M.J. & Hill, R.G. (1994). L-745,337: A selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacology, 33, 1609-1611.
4. Bunting, S., Moncada, S. & Vane, J.R. (1983). The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications. Br. Med. Bull., 39, 271-276.
5. Catella-Lawson, F., McAdam, B., Morrison, B.W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K.C., Quan, H., Gertz, B.J. & Fitzgerald, G.A. (1999). Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J. Pharmacol. Exp. Ther., 289, 735-741.
6. De Nucci, G., Thomas, R., D'Orleans-Juste, P., Antunes, E., Walder, C., Warner, T.D. & Vane, J.R. (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin. Proc. Natl. Acad. Sci. U.S.A., 85, 9797-9800.
7. Edwards, J.C.W., Sedgwick, A.D. & Willoughby, D.A. (1981). The formation of a structure with features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol., 134, 147-156.
8. Flower, R.J. & Vane, J.R. (1972). Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamide-phenol). Nature New Biol., 240, 410-411.
9. Harding, P., Sigmon, D.H., Alfie, M.E., Huang, P.L., Fishman, M.C., Beierwaltes, W.H. & Carretero, O.A. (1997). Cyclooxygenase-2 mediates increased renal content induced by low-sodium diet. Hypertension, 29, 297-302.
10. Harris, R.C., McKanna, J.A., Akai, Y., Jacobson, H.R. & Dubois, R.N. (1994). Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest., 94, 2504-2510.
11. Komhoff, M., Grone, H.J., Klein, T., Seyberth, H.W. & Nusing, R.M. (1997). Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am. J. Physiol., 272, F460-F468.
12. Kubes, P., Suzuki, M. & Granger, D.N. (1991). Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A., 88, 4651-4655.
13. Kujubu, D.A., Fletcher, B.S., Varnum, B.C., Lim. R.W. & Herschman, H.R. (1991). TIS10, a phorbol ester tumor promoter-inducible mRNA from swiss eTe cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266, 12866-12872.
14. McAdam, B.F., Catella-Lawson, F., Mardini, I.A., Kapoor, S., Lawson, J.A. & Fitzgerald, G.A. (1999). Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. U.S.A., 96, 272-277.
15. Mizuno, H., Sakamoto, C., Matsuda, K., Wada, K., Uchida, T., Noguchi, H., Akamatsu, T. & Kasuga, M. (1997). Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology, 112, 387-397.
16. Muscará, M.N. & De Nucci, G. (1996). Simultaneous determination of nitrite and nitrate anions in plasma, urine and cell culture supernatants by high-performance liquid chromatography with post column reactions. J. Chromatogr. B Biomed. Appl., 686, 157-164.
17. Muscará, M.N., McKnight, W., Del Soldato, P. & Wallace, J.L. (1998). Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat. Life Sci., 62, PL235-PL240.
18. Radomski, M. & Moncada, S. (1983). An improved method for washing of human platelets with prostacyclin. Thromb. Res., 30, 383-389.
19. Reuter, B.K., Asfaha, S., Buret, A., Sharkfy, K.A. & Wallace, J.L. (1996). Exacerbation of inflammation-associated colonie injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest., 98, 2076-2085.
20. Sedgwick, A.D., Moore, A.R., Al-Duaij, A.Y., Edwards, J.C. & Willoughby, D.A. (1985). Studies into the influence of carrageenan-induced inflammation on articular cartilage degradation using implantation into air pouches. Br. J. Exp. Pathol., 66, 445-453.
21. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J. & Isakson, P. (1997). Distribution of COX-1 and COX-2 in normal and inflamed tissues. Adv. Exp. Med. Biol., 400, 167-170.
22. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L. & Isakson, P. (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A., 91, 12013-12017.
23. Simon, L.S., Lanza, F.L., Lipsky, P.E., Hubbard, R.C., Talwalker, S., Schwartz, B.D., Isakson, P.C. & Geis, G.S. (1998). Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor - Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum., 41, 1591-1602.
24. Smith, C.J., Zhang, Y., Koboldt, C.M., Muhammad, J., Zweifel, B.S., Shaffer, A., Talley, J.J., Masferrer, J.L., Seibert, K. & Isakson, P.C. (1998). Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. U.S.A., 95, 13313-13318.
25. Vane, J.R. (1994). Towards a better aspirin. Nature, 367, 215-216.
26. Vane, J.R., Mitchell, J.A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J. & Willoughby, D.A. (1994). Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U.S.A., 91, 2046-2050.
27. Wallace, J.L. (1999). Selective COX-2 inhibitors: is the water becoming muddy? Trends Pharmacol. Sci., 20, 4-6.
28. Wallace, J.L., Chapman, K. & McKnight, W. (1999). Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation. Br. J. Pharmacol., 126, 1200-1204.
29. Wallace, J.L., McKnight, W., Miyasaka, M., Tamatani, T., Paulson, J., Anderson, D.C., Granger, D.N. & Kubes, P. (1993). Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am. J. Physiol., 265, G993-G998.
30. Wang, J.L., Cheng, H.R. & Harris, R.C. (1999) Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension, 34, 96-101.
31. Xie, W., Chipman, J.G., Robertson, D.L., Erikson, R.L. & Simmons, D.L. (1991). Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci., 88, 2692-2696.
32. Xie, W., Robertson, D.L. & Simmons, D.L. (1992). Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs. Drug Dev. Res., 25, 249-265.